Profile data is unavailable for this security.
About the company
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
- Revenue in USD (TTM)5.52m
- Net income in USD-12.50m
- Incorporated2008
- Employees53.00
- LocationApplied DNA Sciences Inc50 Health Sciences DriveSTONY BROOK 11790United StatesUSA
- Phone+1 (631) 240-8800
- Fax+1 (631) 240-8900
- Websitehttps://adnas.com/
More ▼
Mergers & acquisitions
| Acquired company | APDN:NAQ since announced | Transaction value |
|---|---|---|
| Spindle Biotech Inc | -66.64% | 2.94m |
Data delayed at least 15 minutes, as of Jul 05 2024 20:59 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optimus Healthcare Services Inc | 1.57m | -8.57m | 3.16m | 12.00 | -- | -- | -- | 2.01 | -0.2139 | -0.2139 | 0.039 | -0.1884 | 0.9263 | -- | 3.12 | 130,884.20 | -505.59 | -- | -- | -- | 83.03 | -- | -545.81 | -- | -- | -7.49 | -- | -- | 22.88 | -- | -3.51 | -- | -- | -- |
| AccuStem Sciences Inc | 0.00 | -1.74m | 3.87m | 3.00 | -- | -- | -- | -- | -0.1537 | -0.1537 | 0.00 | -0.2309 | 0.00 | -- | -- | 0.00 | -1,168.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 45.26 | -- | -- | -- |
| Applied DNA Sciences Inc | 5.52m | -12.50m | 3.97m | 53.00 | -- | -- | -- | 0.7191 | -17.13 | -17.13 | 7.67 | -0.0558 | 0.3893 | 10.38 | 4.64 | 104,110.80 | -87.15 | -88.57 | -111.09 | -121.91 | 33.98 | 44.35 | -223.89 | -113.26 | 1.54 | -- | -- | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| Predictive Oncology Inc | 1.96m | -14.78m | 3.97m | 34.00 | -- | 0.9702 | -- | 2.03 | -3.66 | -3.66 | 0.4853 | 0.9977 | 0.1099 | 1.71 | 4.95 | 57,642.65 | -82.89 | -91.80 | -108.54 | -126.29 | 64.18 | 64.64 | -754.19 | -1,419.99 | 1.35 | -- | 0.0093 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
| Venus Concept Inc | 73.30m | -37.39m | 4.01m | 304.00 | -- | -- | -- | 0.0548 | -6.69 | -6.69 | 13.12 | -3.54 | 0.7409 | 1.06 | 2.21 | 241,125.00 | -37.61 | -32.71 | -56.83 | -44.01 | 68.37 | 68.16 | -50.77 | -48.50 | 1.35 | -3.44 | 1.40 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Sharps Technology Inc | 0.00 | -8.71m | 4.04m | 3.00 | -- | 0.5893 | -- | -- | -0.6204 | -0.6204 | 0.00 | 0.4378 | 0.00 | -- | -- | -- | -74.67 | -- | -95.84 | -- | -- | -- | -- | -- | 0.492 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Therapeutic Solutions International Inc | 97.68k | -2.18m | 4.13m | 3.00 | -- | 2.70 | -- | 42.31 | -0.0006 | -0.0006 | 0.00003 | 0.0003 | 0.0257 | 1.30 | 5.44 | 32,560.00 | -63.47 | -162.32 | -172.17 | -- | 63.36 | 67.79 | -2,468.37 | -2,391.85 | 0.4652 | -6.42 | 0.2868 | -- | -52.13 | 95.35 | 43.11 | -- | -- | -- |
| Reflect Scientific Inc | 1.27m | -343.17k | 4.28m | 7.00 | -- | 2.30 | -- | 3.38 | -0.004 | -0.004 | 0.0148 | 0.0217 | 0.5129 | 0.6184 | 5.72 | 181,111.40 | -13.88 | 11.10 | -16.43 | 13.21 | 56.06 | 62.48 | -27.07 | 10.00 | 2.21 | -- | 0.00 | -- | -47.09 | -6.99 | -613.46 | -- | -- | -- |
| Hawkeye Systems Inc | 0.00 | -804.18k | 4.33m | 44.00 | -- | -- | -- | -- | -0.1186 | -0.1186 | 0.00 | -0.29 | 0.00 | -- | -- | -- | -66.07 | -330.11 | -- | -- | -- | -- | -- | -218.49 | -- | -2.78 | 10.45 | -- | -- | -- | 4.85 | -- | -- | -- |
| Arch Therapeutics Inc | 130.55k | -8.43m | 4.40m | 8.00 | -- | -- | -- | 33.70 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| Dror Ortho-Design Inc | 0.00 | -4.83m | 4.46m | 4.00 | -- | 1.87 | -- | -- | -0.0115 | -0.0115 | 0.00 | 0.0048 | 0.00 | -- | -- | -- | -357.10 | -140.50 | -595.21 | -- | -- | -- | -- | -118,188.00 | -- | -- | 0.00 | -- | -- | -- | -1,896.02 | -- | -- | -- |
| ADM Tronics Unlimited Inc | 2.85m | -716.86k | 4.50m | 7.00 | -- | 4.08 | -- | 1.58 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
| Nu-Med Plus Inc | 0.00 | -119.16k | 4.69m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.002 | 0.00 | -- | -- | 0.00 | -350.01 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -22.74 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
| ReShape Lifesciences Inc | 8.34m | -10.92m | 4.84m | 31.00 | -- | 1.07 | -- | 0.5803 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Pressure Biosciences Inc | 1.98m | -35.20m | 4.86m | 15.00 | -- | -- | -- | 2.46 | -1.65 | -1.65 | 0.0885 | -0.9261 | 1.29 | 2.38 | 8.86 | 131,850.70 | -1,916.46 | -872.30 | -- | -- | 40.43 | 32.33 | -1,482.20 | -1,066.48 | 0.0136 | -0.595 | -- | -- | 14.37 | -4.25 | -97.72 | -- | -- | -- |
Data as of Jul 05 2024. Currency figures normalised to Applied DNA Sciences Inc's reporting currency: US Dollar USD
97.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| AMH Equity Ltd.as of 20 Jun 2024 | 649.81k | 65.99% |
| S.H.N. Financial Investments Ltd.as of 28 May 2024 | 108.00k | 10.97% |
| L1 Capital Global, Inc.as of 28 May 2024 | 108.00k | 10.97% |
| Armistice Capital LLCas of 31 Mar 2024 | 64.80k | 6.58% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 8.68k | 0.88% |
| Geode Capital Management LLCas of 31 Mar 2024 | 6.96k | 0.71% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 5.07k | 0.51% |
| Silverberg Bernstein Capital Management LLCas of 31 Mar 2024 | 4.92k | 0.50% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 3.78k | 0.38% |
| HRT Financial LLCas of 31 Mar 2024 | 2.73k | 0.28% |
More ▼
Data from 31 Mar 2024 - 12 Jun 2024Source: FactSet Research Systems Inc.
